The Chosun Ilbo on MSN
Cha Hyun-seung's Neutrophil Count Stagnates in Leukemia Battle
Actor and dancer Cha Hyun-seung, 34 years old, who revealed his battle with leukemia, shared an update on his current situation. Cha uploaded a video titled *A Day in the Life of a Leukemia Patient* ...
The scientists named this new process ER3D, which stands for endogenous RNA-directed DNA damage. It’s the first time ...
The Body Optimist on MSN
What this young woman thought was a simple dental hygiene problem was hiding something much ...
Her journey illustrates the importance of being alert to even minor signs and seeking a second opinion when a problem ...
What should have been an exciting milestone of kindergarten turned into a life-altering medical crisis for Aida.
City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...
WASHINGTON -- Alex Ovechkin completed his chase of the NHL goals record last season, but the Washington Capitals captain’s ...
Former FBI Director James Comey is set to make his first court appearance in a Justice Department criminal case accusing him ...
Figure Technology Solutions Inc.’s stock rallied 24% in its first day of trading on Thursday in a sign of sustained interest by Wall Street in the fast-growing digital-currency sector. At the closing ...
Developers of advanced artificial intelligence models will need to disclose their safety protocols under a first-in-the-nation law signed Monday by California Gov. Gavin Newsom. The law (SB 53) will ...
The Lakers made a roster move right before the start of training camp with the signing of a former first round pick to a two-way contract. The Los Angeles Lakers have made a series of roster moves ...
Hollywood industries have been struggling with artificial intelligence in music and entertainment, as many fear AI could replace human roles. Adding another concern to the mix is AI actress Tilly ...
– KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval – – KOMET-017-NIC trial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果